Stock Report

All about this stock under one free report Last Updated: 10-Oct-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Alkem Laboratories Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: ALKEM | BSE: 539523

₹5,279.00

up-down-arrow ₹29.50 (0.56%)

As on 09-Oct-2026IST

Market cap

info icon

₹62,954 Cr

Revenue (TTM)

info icon

₹15,081 Cr

P/E Ratio

info icon

29.2

P/B Ratio

info icon

4.4

Div. Yield

info icon

1 %

Edit peer-selector-edit
Alkem Laboratories Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Aurobindo Pharma
Market cap (₹ Cr)
 62,954 1,11,232 99,753 97,850 97,014
Revenue (₹ Cr)
 15,081 28,592 33,228 14,738 34,935
Net Profit (₹ Cr)
 2,206.30 4,492.20 3,169.30 2,055.11 3,712.74
Net Margin (%)
 14.07 14.92 9.15 13.64 10.42
RoE (%)
 16.76 18.78 8.72 13.60 10.38
Price to Earnings
 29.18 24.65 30.96 47.90 26.13
Price-To-Book
 4.40 4.13 2.61 5.82 2.49

Income Statement (₹ Cr)

Alkem Laboratories Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Aurobindo Pharma
Operating Revenue arrow
15,081.28 28,591.70 33,227.90 14,737.88 34,935.29
Total Income arrow
15,680.89 30,111.40 34,650.70 15,061.79 35,624.79
Total Expenditure arrow
12,049.07 21,334.70 28,088.10 10,911.05 27,850.01
EBITDA arrow
3,032.21 7,257.00 5,139.80 3,826.83 7,085.28
Depreciation arrow
394.57 1,724.60 2,119.30 893.20 1,859.31
EBIT arrow
2,637.64 5,532.40 3,020.50 2,933.63 5,225.97
Interest arrow
177.62 510.20 416.30 578.61 387.88
Other Income arrow
599.61 1,519.70 1,422.80 323.91 689.50
Exceptional Items arrow
-187.76 -534.80 0.00 -129.75 -105.51
Profit before Tax arrow
2,871.87 6,007.10 4,027.00 2,549.18 5,422.08
Provision for Tax arrow
665.57 1,514.90 857.70 494.07 1,709.34
Profit after Tax arrow
2,206.30 4,492.20 3,169.30 2,055.11 3,712.74

Liabilities (₹ Cr)

Alkem Laboratories Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Aurobindo Pharma
Shareholder's Funds arrow
13,820.10 27,111.40 37,891.50 16,300.34 37,890.97
Minority Interest arrow
-46.73 -79.70 38.90 -24.90 1.76
Non-Current Liabilities arrow
1,741.34 7,112.50 3,145.10 5,011.23 2,580.33
Current Liabilities arrow
4,782.70 15,711.90 16,747.40 6,507.25 18,039.01
Total Liabilities arrow
20,857.85 50,672.60 56,576.70 27,754.83 58,196.15

Assets (₹ Cr)

Alkem Laboratories Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Aurobindo Pharma
Non-Current Assets arrow
6,708.01 31,677.20 27,204.00 20,274.65 24,040.45
Current Assets arrow
12,210.52 19,906.10 30,179.30 6,954.20 32,708.75
Total Assets arrow
20,857.85 50,672.60 56,576.70 27,754.83 58,196.15
Total Debt* arrow
1,623.50 11,769.50 7,734.10 6,021.78 7,676.20
Net Current Assets arrow
7,427.82 4,194.20 13,431.90 446.95 14,669.74
Contingent Liabilities arrow
1,113.14 989.90 336.14 924.77 1,358.37

Cashflow (₹ Cr)

Alkem Laboratories Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Aurobindo Pharma
Cash From Operating Activities arrow
1,963.03 2,116.60 5,673.70 3,121.29 5,526.37
Cash Flow from Investing Activities arrow
-1,667.21 -8,296.10 -6,549.30 -196.42 -3,458.61
Cash from Financing Activities arrow
-503.40 5,806.90 829.00 -2,952.69 -1,269.15
Net Cash Inflow / Outflow arrow
-207.58 -372.60 -46.60 -27.82 798.61

Ratios

Profitability Ratios

 Alkem Laboratories Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Aurobindo Pharma
ROCE (%) arrow
21.28 21.39 13.75 13.24 12.76
ROE (%) arrow
16.76 18.78 8.72 13.60 10.38
ROA (%) arrow
11.44 10.03 5.89 7.36 6.86
EBIT Margin (%) arrow
17.49 19.35 9.09 19.91 14.96
Net Margin (%) arrow
14.07 14.92 9.15 13.64 10.42
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Alkem Laboratories Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Aurobindo Pharma
Revenue Growth (%) arrow
13.36 21.11 -0.87 14.16 9.09
EBIT Growth (%) arrow
15.78 -8.99 -55.06 19.45 6.91
Net Profit Growth (%) arrow
-5.47 -3.14 -44.66 8.09 8.63
EPS Growth (%) arrow
0.11 4.31 -43.29 12.27 11.88
Book Value Growth (%) arrow
15.36 13.19 12.99 13.74 16.04

Valuation Ratios

 Alkem Laboratories Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Aurobindo Pharma
Price / Earnings arrow
27.66 22.76 30.96 45.52 25.81
Price / Book Value arrow
4.40 4.13 2.61 5.82 2.49
Dividend Yield (%) arrow
1.01 0.09 0.67 0.04 0.24
EV/EBITDA arrow
20.48 15.96 19.55 26.62 13.28
Market Cap (₹ Cr) arrow
63,401.06 87,643.18 1,04,763.81 82,801.75 75,689.14

Solvency Ratios

 Alkem Laboratories Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Aurobindo Pharma
Debt to Equity arrow
0.04 0.12 0.00 0.17 0.02
Short term debt to equity ratio arrow
0.08 0.16 0.16 0.04 0.16
Current Ratio arrow
2.55 1.27 1.80 1.07 1.81
Quick Ratio arrow
1.86 0.91 1.35 0.74 1.15
Interest Coverage arrow
17.17 12.77 10.67 5.41 14.98

Operating Efficiency Ratios

 Alkem Laboratories Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Aurobindo Pharma
Debtors to sales (%) arrow
19.75 18.94 30.47 11.74 20.31
Asset Turnover arrow
0.78 0.64 0.62 0.53 0.65
Receivable days arrow
44.04 33.55 103.79 39.93 33.71
Inventory Days arrow
50.59 33.80 79.94 51.78 59.32
Payable days arrow
167.84 149.82 84.78 111.46 148.20
Cash Conversion Cycle arrow
-73.22 -82.46 98.95 -19.75 -55.17
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...